AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zerosita M 50mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Scott Morrison

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Zerosita M 50mg/500mg Tablet SR

Diabetics with type 2 mellitus may find relief from elevated blood glucose levels with DuoControl 50mg/500mg SR tablets. This dual-action medication manages blood sugar, mitigating the risk of severe diabetic complications like vision impairment and kidney disease, potentially reducing heart attack and stroke incidence. DuoControl 50mg/500mg SR may be used independently or in conjunction with other antidiabetic therapies and is most effective when combined with a balanced diet and regular physical activity. Dosage is individualized based on health status, glucose levels, and existing medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily administration, at the same time each day, maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Adherence to the prescribed diet and exercise plan is crucial for optimal diabetes management, as lifestyle significantly impacts glycemic control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential risk, particularly when co-administered with insulin or sulfonylureas; therefore, understanding its recognition and management is essential. This medication isn't suitable for everyone. Prior to use, individuals with pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption should consult their physician. Pregnant or lactating women should seek medical advice. Potential drug interactions exist; therefore, complete disclosure of all medications to your doctor is vital for safety. Alcohol consumption should be minimized due to its hypoglycemic effects. Kidney function and blood glucose will be monitored by your doctor before, during, and after treatment.

Uses of Zerosita M 50mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Zerosita M 50mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Zerosita M 50mg/500mg Extended-Release tablets with food.

Common Side effects of Zerosita M 50mg/500mg Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Zerosita M 50mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Zerosita M 50mg/500mg Extended-Release Tablet with food.

How Zerosita M 50mg/500mg Tablet SR works:

Zerosita M 50mg/500mg sustained-release tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Zerosita M 50mg/500mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Zerosita M 50mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Zerosita M 50mg/500mg tablet is likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is a potential consequence of both hypoglycemia and hyperglycemia. Refrain from operating a vehicle if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Zerosita M 50mg/500mg SR tablets, as dosage modification may be necessary. Individuals with severe kidney disease should avoid this medication. Close monitoring of kidney function is recommended during treatment with Zerosita M 50mg/500mg SR tablets; consult your physician for guidance.

LiverLiverUNSAFE

The extended-release Zerosita M 50mg/500mg tablet is likely to pose a risk for individuals with hepatic impairment and its use should be avoided. Medical advice is recommended.

What if you forget to take Zerosita M 50mg/500mg Tablet SR :

Should you forget a Zerosita M 50mg/500mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zerosita M 50mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes medication

FAQs on Zerosita M 50mg/500mg Tablet SR

Zerosita M 50mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Zerosita M 50mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Zerosita M 50mg/500mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Zerosita M 50mg/500mg Tablet SR is contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Zerosita M 50mg/500mg SR tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Yes, Zerosita M 50mg/500mg SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect necessitates avoiding Zerosita M in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Zerosita M and seek immediate medical attention.
Zerosita M 50mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Zerosita M 50mg/500mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Zerosita M 50mg/500mg Tablet SR components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Zerosita M 50mg/500mg SR tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Zerosita M 50mg/500mg Tablet SR. This condition results from excessive lactic acid in the blood. Because it's rare, metformin is avoided in patients with kidney disease, older adults, and heavy alcohol users. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Zerosita M 50mg/500mg SR tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some research.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Zerosita M 50mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Zerosita M 50mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Zerosita M 50mg/500mg Tablet SR is contraindicated in patients with known allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Zerosita M 50mg/500mg SR tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Zerosita M 50mg/500mg Tablet SR. This rare complication is more likely in patients with kidney disease, older individuals, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Zerosita M 50mg/500mg SR tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Zerosita M 50mg/500mg Tab...
106
MRP 123
13% off